Clinical trial
Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of VYTORIN in Usual Practice
NCT01070966 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of VYTORIN in Usual Practice
- Lead sponsor
- Organon and Co
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- April 30, 2010
- Enrollment
- 2,089 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary hypercholesterolemia and homozygous familial hypercholesterolemia (hofh)